Steady Expansion Forecast for Veterinary Pharmaceuticals Market, Projected to Reach $50.59 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Veterinary Pharmaceuticals Market Size Growth Forecast: What to Expect by 2025?
The market for veterinary pharmaceuticals has seen solid growth over the past few years. Its size is expected to expand from $35.36 billion in 2024 to $37.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.1%. This growth during the historic period is due to a variety of factors including a higher number of pets, an increase in individual spending on pets, the rise in use of e-commerce platforms for online pharmacies, growth in emerging markets, increased government initiatives, and a rise in disease prevalence.

How Will the Veterinary Pharmaceuticals Market Size Evolve and Grow by 2029?
Expectations are high for significant expansion in the veterinary pharmaceuticals market in the upcoming years. The market is predicted to reach $50.59 billion in 2029, progressing at a compound annual growth rate (CAGR) of 7.5%. Fluctuations in this projected period can be influenced by factors such as rising pet ownership, population growth, increased disposable income, urbanization, deeper infiltration of pet insurance, and expanded government support. Key trends in the projected period encapsulate the emphasis on stem cell therapy for animal treatment, greater application of nanotechnology in veterinary drugs to combat antibiotic resistance, the creation of chewable tablets, deployment of telemedicine platforms to lessen COVID-19 impact, production of sophisticated vaccines, focus on super-combo parasiticides, application of subunit and virus-like particle (VLP)-based vaccines, and a directed focus on strategic alliances and collaborations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

What Drivers Are Propelling the Growth of Veterinary Pharmaceuticals Market Forward?
One of the key factors driving the growth of the veterinary pharmaceuticals market is the escalating rate of disease prevalence among animals. An uptick in occurrences of illnesses in livestock and pet animals necessitates the use of medicines to combat these ailments. For example, the Banfield State of Pet Health Report indicates that dog diabetes prevalence has risen by 79.7%, going from 13.1 cases per 10,000 to 23.6 cases. Cats have also seen a prevalence increase of 18%. This surge in disease frequency among animals consequently leads to a heightened demand for the veterinary pharmaceuticals market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3809&type=smp

Which Emerging Trends Are Transforming the Veterinary Pharmaceuticals Market in 2025?
The emergence of generic medications for pet healthcare is being identified as a new trend in the veterinary pharmaceuticals market. The affordability of these generic drugs allows pet owners to take care of their animals effectively. The FDA has given the green light to 22 generic animal medications for cats and dogs, leading to an increase in their use by veterinarians. Based on a study conducted on 520 veterinarians by Brakke and Trone Brand Energy Inc., about 80% of vets confirmed they use generic medications to help save pet owners money. However, the reduced profit margins offered by generic drug producers, in comparison to the hefty margins from branded drugs, demand closer examination by veterinarians.

What Are the Key Segments in the Veterinary Pharmaceuticals Market?
The veterinary pharmaceuticals market covered in this report is segmented -

1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals
2) By Type Of Animal: Livestock, Companion Animals
3) By Type Of Vaccine: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines
4) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration
5) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores

Subsegments:
1) By Veterinary Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines
2) By Veterinary Antibiotics: Penicillins, Cephalosporins, Tetracyclines, Fluoroquinolones, Macrolides
3) By Veterinary Parasiticides: Endoparasiticides, Ectoparasiticides, Endectocides, Antiprotozoals
4) By Other Veterinary Pharmaceuticals: Anti-inflammatory Drugs, Analgesics, Hormonal Medications, Antifungals

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3809&type=smp

Who Are the Key Players Shaping the Veterinary Pharmaceuticals Market's Competitive Landscape?
Major companies operating in the veterinary pharmaceuticals market include Zoetis Inc, Merck & Co., Inc, Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Trifecta Pharmaceuticals USA LLC., Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd , UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., Global Vet (U) Ltd

What Geographic Markets Are Powering Growth in the Veterinary Pharmaceuticals Market?
North America was the largest region in the veterinary pharmaceuticals market in 2024. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3809

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.